Anti-cancer adjuvant drug screening via epithelial-mesenchymal transition-related aptamer probe
- 21 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Analytical and Bioanalytical Chemistry
- Vol. 413 (28), 6951-6962
- https://doi.org/10.1007/s00216-021-03669-x
Abstract
Epithelial-mesenchymal transition (EMT) is implicated in the pathological processes of cancer metastasis and drug resistance. Anti-cancer drugs may also potentially lead to EMT, resulting in their reduced therapeutic effect. Therefore, the combination of these anti-cancer drugs with anti-EMT agents has been promoted in clinic. Screening anti-EMT drugs and evaluation of EMT process are highly dependent on EMT biomarkers on cell membrane. At present, the detection of EMT biomarker is mainly by Western blot method, which is time-consuming and complicated. In this work, for effectively screening anti-EMT drugs by evaluation of the EMT process, a type of aptamer probe based on aggregation-induced emission (AIE) was designed. The aptamer SYL3C was employed to target the EMT biomarker EpCAM on cell membrane. Two fluorophores, FAM and tetraphenylethene (TPE, an AIE dye), were modified at the two ends of SYL3C, respectively. This aptamer probe (TPE-SYL3C-FAM) can monitor the EpCAM expression, which can be recovered by anti-EMT drugs. By observation of the change in TPE emission intensity, the anti-EMT effect of drugs can be evaluated. The FAM emission was used as internal reference to reduce environmental interferences. This probe can be potentially used to screen anti-EMT agents as anti-cancer adjuvant drugs with high throughput. Graphical abstractKeywords
Funding Information
- "Double First-Class" University project (No. CPU2018GY34)
- Fundamental Research Funds for the Central Universities (No. 2632018ZD11)
- National Natural Science Foundation of China (Grant No. 82073815)
This publication has 40 references indexed in Scilit:
- Molecular mechanisms of epithelial–mesenchymal transitionNature Reviews Molecular Cell Biology, 2014
- Tumor metastasis: moving new biological insights into the clinicNature Medicine, 2013
- Cancer drug resistance: an evolving paradigmNature Reviews Cancer, 2013
- Bioprobes Based on AIE FluorogensAccounts of Chemical Research, 2013
- Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell CaptureAnalytical Chemistry, 2013
- EMT: When epithelial cells decide to become mesenchymal-like cellsJCI Insight, 2009
- Aptamer-based biosensorsTrAC Trends in Analytical Chemistry, 2008
- Phosphine Dendrimer-Stabilized Palladium Nanoparticles, a Highly Active and Recyclable Catalyst for the Suzuki−Miyaura Reaction and HydrogenationOrganic Letters, 2006
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990